Lexeotx

Verified

1 open roles · New York, United States

Work at Lexeotx.

Lexeo Therapeutics is a clinical-stage genetic medicine company developing AAV-based gene therapies for cardiovascular diseases and APOE4-associated Alzheimer's disease. Its lead candidate, LX2006, targets Friedreich ataxia cardiomyopathy. The company is publicly traded on Nasdaq...

Biotechnology
Open roles 1
Founded 2017
Type Public
Team size 51–200
Headquarters New York, United States
Website lexeotx.com
View on LinkedIn →

Subscribe to Career Resources

Get the latest career advice, industry insights, and job opportunities delivered to your inbox.